Diagnostics

BraineHealth redefines diagnostics with US Patent 11,908,579 B2 and Diagnosio’s AI technology, achieving 99% accuracy through inversion methods.

Developed from a 2018 KTH thesis, it scales to 20,000+ cases, outperforming Microsoft’s MAI-DxO with dynamic decision-making. Featured in USA News, BizWeekly.com and AP across 450+ outlets, this innovation enhances healthcare, finance, and engineering diagnostics. License it today.

Key Features:

Precision Diagnostics: 99% accuracy for reliable results.

Global Scalability: Adapts to diverse diagnostic needs.

License the Patent | Contact Us to collaborate.